Fosun Pharma: controlled subsidiary's Sodium Thiosulfate Injection approved for registration

Fosun Pharma announced that its holding subsidiary, Chongqing Kelun Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the drug registration application for Sodium Thiosulfate Injection. The indications approved for this application are for use in cyanide poisoning, as well as arsenic, mercury, lead, bismuth, iodine poisoning.